Who is using Auvelity for depression?

This study is the first to analyse real-world use of Auvelity (dextromethorphan HBr and bupropion HCL, 45 mg/105 mg extended-release tablets) for treating major depressive disorder (MDD) in the United States. Researchers reviewed medical records of over 22,000 adults, examining factors like age, gender, insurance, and previous depression treatments. Findings revealed that patients across a wide range of demographics began using AUVELITY. About one-third of patients started using it alone, as a monotherapy, and a variety of healthcare professionals prescribed it. This research offers insights into real-world use of AUVELITY.

Original article:

Muzyk A, Syed FZ, Zhou H, et al. Real-world treatment patterns of patients with major depressive disorder treated with Auvelity in the United States. J Med Econ. 2024;27(1):1003-1010. doi:10.1080/13696998.2024.2382641